Sunday, March 29



UCLA Fielding School of Public Health names Ronald Brookmeyer as new dean

The interim dean for the UCLA Fielding School of Public Health will assume the role effective Jan. 15. Ronald Brookmeyer, a biostatistics professor, has served as interim dean of the School of Public Health since November 2018 and has been UCLA faculty member since 2010. Read more...

Photo: Ronald Brookmeyer, the interim dean for the UCLA Fielding School of Public Health and a biostatistics professor, will assume the role effective Jan. 15. Brookmeyer has been a member of UCLA faculty since 2010. (Courtesy of UCLA Newsroom)


Study explains mechanism that may be linked to development of Type 2 diabetes

A UCLA-led study may explain the development of Type 2 diabetes, suggesting potential new methods to treat the condition. Orian Shirihai, a professor of endocrinology and pharmacology at UCLA’s David Geffen School of Medicine, led the research team that found a novel mechanism that may be responsible for driving insulin oversecretion, according to a university press release published Dec. Read more...

Photo: A research team led by Orian Shirihai, a professor at the David Geffen School of Medicine at UCLA, undertook a study that may explain the development of Type 2 diabetes and suggest potential new ways to treat the condition. (Daily Bruin file photo)


Study unveils new way to predict risk of death for stable heart failure patients

The findings of a UCLA-led study may allow for medical professionals to identify patients with stable heart failure who are at risk. UCLA cardiologist Olujimi Ajijola was the first author of a study that found a new way to detect which patients with “stable” heart failure have a higher risk of dying within one to three years. Read more...

Photo: A UCLA-led study found that neuropeptide Y, an amino acid released by the nervous system, is a significant indicator of which patients have a higher risk of dying within a few years. (Daily Bruin file photo)





1 115 116 117 118 119 341